Ethiopropamine (EPA), also known as N-ethylthiopropamine, is a stimulant drug which is the ethyl homologue of methiopropamine, or the thiophene analogue of ethamphetamine. It has been sold as a designer drug, first identified in Slovenia in 2021.[1]

See also

References

  1. ^ "Analytical Report Ethiopropamine" (PDF). Nacionalni Forenzicni Laboratorij. 23 July 2021.
Allikas: http://en.wikipedia.org/wiki/Ethiopropamine
No tags for this post.